about
Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.Morphometric analysis of caudate veins for advanced liver surgery.Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience.Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma.Strategies for surgical treatment of gallbladder carcinoma based on information available before resection.Clinical application of TcGSA.Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.Current role of portal vein embolization/hepatic artery chemoembolization.Surgery for multiple hepatic colorectal metastases.Bilioenteric reconstruction for small bile ducts without mucosa-to-mucosa alignment: long-term results.Assessment of Preoperative Liver Function in Patients with Hepatocellular Carcinoma - The Albumin-Indocyanine Green Evaluation (ALICE) Grade.Surgical treatment for metastatic malignancies. Nonanatomical resection of liver metastasis: indications and outcomes.Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled TrialRisk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinomaSurgical management of hepatocellular carcinoma. Liver resection and liver transplantation.Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan.Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.Recurrence of cholestatic liver disease after living donor liver transplantationRadical resection of biliary tract cancers and the role of extended lymphadenectomy.Single HCC between 2 and 5 cm: the grey zone: surgeon's perspective.Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.Donor quality of life after living donor liver transplantation: a prospective study.Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases.Eleven-year survivor of unresectable intrahepatic cholangiocarcinoma treated using long-term UFT therapy.Demonstration of quality of care measurement using the Japanese liver cancer registry.Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma: a Novel Nomogram from the "HCC East & West Study Group".Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: association with metastatic potential and cell morphology.Surgical Site Infection after Hepatectomy for Hepatocellular Carcinoma.Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy.Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma.Epidermal growth factor-mediated growth control of confluent mammary epithelial cells cultured on artificial basement membrane.Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases.The Feasibility of Third or More Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma.Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver CirrhosisDissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physiciansEWALT: East Meets West in a Multidisciplinary Setting to Improve the Management of Liver Tumors.Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan
P50
Q33829875-3FF96F40-C701-430B-8991-3767C28A3224Q34394455-C715BE3C-7C12-4E8F-8F9A-67BF831CF1AAQ34563749-D6748592-EE30-4DF4-A534-3DE3448A8A79Q34593071-DE05825F-7FE2-4363-BAB7-4D4D3D26DA0EQ35055436-5A9DFE7D-0B02-4B68-AF30-BAA8773FFF8CQ35073911-D7C5FA30-ED20-40E7-A3A7-00BD9AC39A0CQ35177785-782A0FB0-DC42-40BF-8AD3-A1180D32C050Q35617877-78ED38D4-C3D9-4D21-AE6C-705A35A49AD3Q35698198-48245331-06B4-4260-872E-A014C5676D1FQ35737403-87426856-F0CC-44AF-814E-63F8B8FC2D59Q35764607-6B3FDCCB-04EA-4EB3-AAB5-EFF0EF7BC5F0Q35921872-855CDC2A-3DB6-42D9-AA22-B9E36A1B4810Q36081643-D7AD3CE7-5830-4D6D-BAAB-AC1E90AD6471Q36112107-90681E22-B6BB-4322-ADFB-5455F933E887Q36121535-C72ADBA5-9736-4A2C-8CE9-84BFA46616A3Q36498474-2CA0CF51-B090-40EA-A1D0-785421054BCFQ36901614-0A0F3ADC-EAA1-42F8-877A-5A59F1F54A23Q37014868-FA587179-EB4E-45A5-8FC0-38DF1D237D3AQ37124700-873FB597-CAE4-41EA-BF57-A1A826B4349DQ37262983-80207634-468B-40AF-A221-52079BA9033EQ37420877-6F4644B2-977B-4322-A613-9C786CDE3F3EQ37627643-C7504789-8BBC-4387-AD12-8E9653C14111Q37793324-4CD363C8-D94F-4B35-AD75-85AF538E5C8AQ37806128-C48526AB-AAAD-4734-B5D9-42568B7AE7AEQ39022926-8591A93C-8E06-4795-96F7-0401642D9287Q39209604-E7153517-E5D3-46A8-9010-9616BF5562CAQ39700172-2560FB29-D8FF-4A25-90F7-100B82AFC846Q39898473-86AD0ABE-5661-473D-9CCD-D480B1642A26Q40153525-608FC70F-E789-424A-A8DA-7C2E751AAD9EQ40163569-54304B46-E2D3-4CAB-A501-718010E5E287Q40250455-9061D757-DB81-4143-96FD-E055921016A0Q40388777-888B1729-FD1F-48B9-A31C-BCD989364384Q40389618-ABCDE5A5-C352-471A-9D50-913DE22D0435Q40497024-16815AF4-B328-4D43-8042-1F513B6889B4Q41205839-030D8F04-5DA3-4A0E-B106-04020256986DQ41755982-D34E7E0E-FBED-4C56-A9C7-203C277FC2D1Q41864202-AD6BE5C7-22BC-4DC5-A24D-78FE9CEA509AQ42339720-C084CCC3-BDF5-4F16-B493-187187FD0694Q42351585-7D0A80F1-E937-4AE7-851E-E459086BD16CQ42704646-6E8F0D8C-C813-4340-976D-0E6000BF2C0E
P50
name
Masatoshi Makuuchi
@en
type
label
Masatoshi Makuuchi
@en
prefLabel
Masatoshi Makuuchi
@en